Blood serum amyloid A as potential biomarker of pembrolizumab efficacy for patients affected by advanced non-small cell lung cancer overexpressing PD-L1: results of the exploratory "FoRECATT" study
| Image |  |
|---|---|
| Description | scientific article published on 24 November 2020 |
| Author/s |
author: Vincenzo Di Noia Giampaolo Tortora |
| Publication date | November 24, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |